Louis Iorio

Title: The Innovative Contributions of Inventor Louis Iorio

Introduction

Louis Iorio, an accomplished inventor from Lebanon, NJ, has made significant contributions to the field of pharmaceuticals. With two patents to his name, he has developed methods that advance the understanding of receptor activities in the brain, which are critical for the development of anxiolytic drugs.

Latest Patents

Iorio's latest patents include a "Method for measuring the BZ-1 receptor binding activity in a test sample," which outlines a process for determining the BZ-1 receptor activity of test samples or potential anxiolytic drugs. His other patent, an "Assay for D-1 antagonistic activity of neuroleptic drugs," presents a method, reagents, and kit designed to measure the levels of D-1 receptor antagonistic activity. This method correlates the competition between an analyte and tritiated R-(+)-8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol for binding to D-1 receptors found in mammalian brain tissue.

Career Highlights

Throughout his career, Iorio has been associated with Schering Corporation, a leading company in the pharmaceutical sector. His work has directly contributed to advances in neuropharmacology, showcasing his commitment to improving mental health treatments.

Collaborations

Iorio has collaborated with notable colleagues, including Allen Barnett and William Billard, who have also contributed to the research and development in the fields related to neuroleptic drugs and receptor activities. These partnerships have further enhanced the effectiveness and reach of his inventions.

Conclusion

In conclusion, Louis Iorio stands out as a significant inventor in the pharmaceutical industry. His patents reflect innovative methods that aid in the understanding of brain receptors, providing the groundwork for potential breakthroughs in anxiety and psychotropic medications. Through his work and collaborations, Iorio continues to pave the way for advancements that benefit the field of mental health.